The Globe and Mail reports in its Friday, June 13, edition that CIBC Capital Markets analyst Krista Friesen raised her share target on Atkinsrealis Group to $106 from $92, while maintaining an "outperformer" recommendation. The Globe's David Berman writes that the increase follows the sale of its remaining interest in Highway 407, providing about $2.2-billion for debt repayment, share buybacks and expansions. Ms. Friesen is upbeat on the company's growing nuclear business. She says in a note, "While Canada remains the backbone of Atkinsrealis Group's nuclear business, we believe the company is increasingly well positioned to capture international opportunities as nuclear energy re-emerges as a key pillar in global decarbonization strategies." Atkinsrealis is one of the few engineering firms with end-to-end capabilities across the nuclear life cycle. Ms. Friesen reported that the company's nuclear project backlog rose to $5.2-billion by the end of the first quarter, a 185-per-cent increase year-over-year and 64 per cent from the previous quarter. The nuclear segment is now projected to generate revenue of $1.9-billion to $20-billion in 2025, up from a previous estimate of $1.6-billion to $1.7-billion.